Pfizer Global Product DevelopmentCollegeville, Pennsylvania, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
2893 A - Efficacy and Safety of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Gram-Negative Bacteria, Including Metallo-β-Lactamase-Producing Pathogens: Phase 3 REVISIT Study
Saturday, October 14, 20232:35 PM – 2:45 PM US ET